Current Report · Items 5.02, 9.01 · 8-K

PetVivo Holdings, Inc.

PETVOTCEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 Press Release dated September 22, 2026 104 Cover Page Interactive Data File (formatted as Inline XBRL)

Filed Sep 22, 2026Accepted Sep 22, 2026, 7:00 AM EDTCIK 1512922Accession 0001493152-26-043641

View company →Permanent SEC source ↗

Company context

Current securities

PETVOTC · EQUITY · Current PETVWOTC · WARRANT · Current

Historical securities (1)

PETVDOTC · EQUITY · Historical · closed Jan 29, 2021

Recent company filings

Registered securities in this filing

PETVIVO HOLDINGS, INC. · 8-K · Filed 2026-09-22

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol: PETV
Exchange: OTC
Classification: COMMON
Status: Current

Filing context

Context: AsOf2026-09-22

Dimensions: Not supplied

Accession 000149315226043641 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 9.01Item 9.01 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 Press Release dated September 22, 2026 104 Cover Page Interactive Data File (formatted as Inline XBRL)

Filed exhibits (1)

EX-99.1 (by filename) ex99-1.htm

Exhibit 99.1 5151 Edina Industrial Blvd., Suite 575, Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: Michael Handley Joins PetVivo Holdings, Inc. Board of Directors MINNEAPOLIS, MN, US, September 22, 2026 - PetVivo Holdings, Inc. (OTCQX: PETV) (the “Company”), together with its subsidiaries PetVivo Animal Health, Inc., Somatrix Technologies, Inc. and PetVivo AI, Inc., an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, today announced the appointment of Michael K. Handley to its Board of Directors, effective September 22, 2026. “We are pleased to welcome Michael Handley to PetVivo’s Board of Directors,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “Michael brings extensive experience in building life sciences companies, raising capital and guiding technologies through development and commercialization. His perspective across biotechnology, pharmaceuticals and medical devices will be valuable as we work to expand adoption of our products, evaluate strategic opportunities and build long-term shareholder value.” Mr. Handley is a life sciences exec…

Open exhibit ↗